keyword
Keywords kidney diseases, diabetes, end...

kidney diseases, diabetes, endocrine diseases

https://read.qxmd.com/read/38648832/management-of-type-2-diabetes-mellitus-with-noninsulin-pharmacotherapy
#1
JOURNAL ARTICLE
Elizabeth M Vaughan, Zuleica M Santiago-Delgado
Type 2 diabetes mellitus is a chronic disease that is increasing in global prevalence. An individualized approach to pharmacotherapy should consider costs, benefits beyond glucose control, and adverse events. Metformin is the first-line therapy due to its low cost and effectiveness. Sulfonylureas and thiazolidinediones are additional low-cost oral hypoglycemic classes available in the United States; however, evidence shows variability in weight gain and hypoglycemia. Thiazolidinediones increase fluid retention and are not recommended in patients with New York Heart Association class III or IV heart failure...
April 2024: American Family Physician
https://read.qxmd.com/read/38638974/the-biological-functions-and-pathological-mechanisms-of-cask-in-various-diseases
#2
REVIEW
Xingjing Liu, Haonan Qin, Yuanyuan Liu, Jingjing Ma, Yiming Li, Yu He, Huimin Zhu, Li Mao
BACKGROUND: As a scaffold protein, calcium/calmodulin-dependent serine protein kinase (CASK) has been extensively studied in a variety of tissues throughout the body. The Cask gene is ubiquitous in several tissues, such as the neurons, islets, heart, kidneys and sperm, and is mostly localised in the cytoplasm adjacent to the basement membrane. CASK binds to a variety of proteins through its domains to exerting its biological activity. SCOPE OF REVIEW: Here, we discuss the role of CASK in multiple tissues throughout the body...
April 30, 2024: Heliyon
https://read.qxmd.com/read/38630049/advancements-in-diabetic-kidney-disease-management-integrating-innovative-therapies-and-targeted-drug-development
#3
REVIEW
Shaarav Ghose, Matthew Satariano, Saichidroopi Korada, Thomas Cahill, Raghav Shah, Rupesh Raina
Diabetic kidney disease (DKD) is a leading cause of chronic kidney disease and affects approximately 40% of diabetic individuals. Cases of DKD continue to rise globally as the prevalence of diabetes mellitus increases, with an estimated 415 million people living with diabetes in 2015 and a projected 642 million by 2040. DKD is associated with significant morbidity and mortality, representing 34% and 36% of all chronic kidney disease deaths in men and women, respectively. Common co-morbidities including hypertension and ageing-related nephron loss further complicate disease diagnosis and progression...
April 17, 2024: American Journal of Physiology. Endocrinology and Metabolism
https://read.qxmd.com/read/38627329/hypertension-and-diabetes-but-not-leptin-and-adiponectin-mediate-the-relationship-between-body-fat-and-chronic-kidney-disease
#4
JOURNAL ARTICLE
Robin Lengton, Friedo W Dekker, Elisabeth F C van Rossum, Johan W de Fijter, Frits R Rosendaal, Ko Willems van Dijk, Ton J Rabelink, Saskia Le Cessie, Renée de Mutsert, Ellen K Hoogeveen
PURPOSE: Obesity may promote kidney damage through hemodynamic and hormonal effects. We investigated the association between body mass index (BMI), total body fat (TBF) and chronic kidney disease (CKD) and whether hypertension, diabetes, leptin and adiponectin mediated these associations. METHODS: In this cross-sectional analysis of the Netherlands Epidemiology of Obesity study, 6671 participants (45-65 y) were included. We defined CKD as eGFR <60 ml/min/1...
April 16, 2024: Endocrine
https://read.qxmd.com/read/38626908/young-onset-diabetes-in-east-asians-from-epidemiology-to-precision-medicine
#5
JOURNAL ARTICLE
Juliana C N Chan, Chun-Kwan O, Andrea O Y Luk
Precision diagnosis is the keystone of clinical medicine. In East Asians, classical type 1 diabetes is uncommon in patients with youngonset diabetes diagnosed before age of 40, in whom a family history, obesity, and beta-cell and kidney dysfunction are key features. Young-onset diabetes affects one in five Asian adults with diabetes in clinic settings; however, it is often misclassified, resulting in delayed or non-targeted treatment. Complex aetiologies, long disease duration, aggressive clinical course, and a lack of evidence-based guidelines have contributed to variable care standards and premature death in these young patients...
April 16, 2024: Endocrinology and Metabolism
https://read.qxmd.com/read/38623181/safety-and-efficacy-of-semaglutide-in-post-kidney-transplant-patients-with-type-2-diabetes-or-post-transplant-diabetes
#6
JOURNAL ARTICLE
Moeber Mohammed Mahzari, Omar Buraykan Alluhayyan, Mahdi Hamad Almutairi, Mohammed Abdullah Bayounis, Yazeed Hasan Alrayani, Amir A Omair, Awad Saad Alshahrani
OBJECTIVE: Type 2 diabetes mellitus (T2DM) and post-transplant diabetes mellitus (PTDM) are common in renal transplant recipients. Semaglutide has demonstrated efficacy and safety in patients with T2DM. To date, only a limited number of studies have investigated its use in renal transplant patients. This study assessed the safety and efficacy of semaglutide in post-renal transplant patients. METHODS: A retrospective study was conducted at king Abdulaziz Medical City-Riyadh, Saudi Arabia...
June 2024: Journal of Clinical & Translational Endocrinology
https://read.qxmd.com/read/38616273/sodium-bicarbonate-and-intubation-in-severe-diabetic-ketoacidosis-are-we-too-quick-to-dismiss-them
#7
JOURNAL ARTICLE
Manudi Vidanapathirana
Management of diabetic ketoacidosis (DKA) has internationally established guidelines. However, management of severe, refractory DKA with multiple contributors to acidosis, and management of DKA in patients with altered mentation, remain ambiguous. Use of sodium bicarbonate and intubation in DKA are unpopular treatment practices, but warrant consideration in these unique clinical scenarios. This paper describes a 61-year-old Sri Lankan female who presented with severe DKA, seizures and altered level of consciousness...
April 15, 2024: Clinical Diabetes and Endocrinology
https://read.qxmd.com/read/38601207/research-progress-on-the-mechanism-of-tcm-regulating-intestinal-microbiota-in-the-treatment-of-dm-mellitus
#8
REVIEW
Yang Ping, Jianing Liu, Lihong Wang, Hongbin Qiu, Yu Zhang
In recent years, with the improvement of people's living standards, the incidence of DM has increased year by year in China. DM is a common metabolic syndrome characterized by hyperglycemia caused by genetic, environmental and other factors. At the same time, long-term suffering from DM will also have an impact on the heart, blood vessels, eyes, kidneys and nerves, and associated serious diseases. The human body has a large and complex gut microbiota, which has a significant impact on the body's metabolism...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38599609/association-between-liver-fibrosis-score-and-diabetic-kidney-disease-a-retrospective-cross-sectional-study-of-hospitalized-patients
#9
JOURNAL ARTICLE
Jie Zhang, Shen Chen, Zhendong Tian, Jiarui Cao, Yijie Jiao, Bangqi Wang, Shenghui Feng, Zhanpeng Luo, Qingfang Zhang, Yuanyuan Deng, Wei Cai, Jixiong Xu
OBJECTIVES: To investigate the association between liver fibrosis score and diabetic kidney disease (DKD) in type 2 diabetes mellitus (T2DM). METHODS: A total of 897 hospitalized patients with T2DM were included in this study. Each patient completed DKD screening. Logistic regression analysis was used to assess the predictive value of non-alcoholic fatty liver disease fibrosis score (NAFLD-FS) and fibrosis-4 (FIB-4) for the occurrence of DKD and risk for DKD progression, respectively...
April 10, 2024: Experimental and Clinical Endocrinology & Diabetes
https://read.qxmd.com/read/38586459/associations-of-comorbid-depression-with-cardiovascular-renal-events-and-all-cause-mortality-accounting-for-patient-reported-outcomes-in-individuals-with-type-2-diabetes-a-6-year-prospective-analysis-of-the-hong-kong-diabetes-register
#10
JOURNAL ARTICLE
Yiu-Lam Yeung, Ka-Long Lee, Eric Sh Lau, Tsun-Fung Yung, Aimin Yang, Hongjiang Wu, Kelly Tc Wong, Alice Ps Kong, Elaine Yk Chow, Ronald Cw Ma, Theresa Yeung, Kit-Man Loo, Risa Ozaki, Andrea Oy Luk, Juliana Nm Lui, Juliana Cn Chan
BACKGROUND: Psychosocial status and patient reported outcomes (PRO) [depression and health-related quality-of-life (HRQoL)] are major health determinants. We investigated the association between depression and clinical outcomes in Chinese patients with type 2 diabetes (T2D), adjusted for PRO. METHODS: Using prospective data from Hong Kong Diabetes Register (2013-2019), we estimated the hazard-ratio (HR, 95%CI) of depression (validated Patient Health Questionnaire 9 (PHQ-9) score≥7) with incident cardiovascular disease (CVD), ischemic heart disease (IHD), chronic kidney disease (CKD: eGFR<60 ml/min/1...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38586458/external-validation-of-a-minimal-resource-model-to-predict-reduced-estimated-glomerular-filtration-rate-in-people-with-type-2-diabetes-without-diagnosis-of-chronic-kidney-disease-in-mexico-a-comparison-between-country-level-and-regional-performance
#11
JOURNAL ARTICLE
Camilla Sammut-Powell, Rose Sisk, Ruben Silva-Tinoco, Gustavo de la Pena, Paloma Almeda-Valdes, Sonia Citlali Juarez Comboni, Susana Goncalves, Rory Cameron
BACKGROUND: Patients with type 2 diabetes are at an increased risk of chronic kidney disease (CKD) hence it is recommended that they receive annual CKD screening. The huge burden of diabetes in Mexico and limited screening resource mean that CKD screening is underperformed. Consequently, patients often have a late diagnosis of CKD. A regional minimal-resource model to support risk-tailored CKD screening in patients with type 2 diabetes has been developed and globally validated. However, population heath and care services between countries within a region are expected to differ...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38585445/age-related-markers-and-predictors-of-diabetic-kidney-disease-progression-in-type-2-diabetes-patients-a-retrospective-cohort-study
#12
JOURNAL ARTICLE
Larissa Fabre, Érika Bevilaqua Rangel
BACKGROUND: Diabetic kidney disease (DKD) is characterized by reduced estimated glomerular filtration rate (eGFR) and albuminuria, which play a pivotal role in both diagnosing and determining the disease's progression. This study aimed to assess the trajectory of these markers concerning age in individuals with DKD and identify predictive factors for the decline in eGFR decline, variation in albuminuria, mortality, and progression to renal replacement therapy (RRT). DESIGN: This retrospective cohort encompassed patients with type 2 diabetes (T2D), divided into two age categories: <75 and ⩾75 years old...
2024: Therapeutic Advances in Endocrinology and Metabolism
https://read.qxmd.com/read/38585386/olfactory-function-in-diabetes-mellitus
#13
REVIEW
Beata Sienkiewicz-Oleszkiewicz, Thomas Hummel
Diabetes mellitus (DM) is an increasingly common disease in both children and adults. In addition to neuronal and/or vascular disorders, it can cause chemosensory abnormalities including olfactory deterioration. The purpose of this article is to summarize current knowledge on olfactory function in DM, highlighting the impact of co-morbidities, especially obesity, thyroid dysfunction, chronic kidney disease and COVID-19 on olfactory outcomes. Research to date mostly shows that olfactory impairment is more common in people with diabetes than in the general population...
June 2024: Journal of Clinical & Translational Endocrinology
https://read.qxmd.com/read/38577568/relationship-between-blood-cadmium-levels-and-bone-mineral-density-in-adults-a-cross-sectional-study
#14
JOURNAL ARTICLE
Yi Lei, Meiqian Guo, Juan Xie, Xueqing Liu, Xiang Li, Hongwu Wang, Yong Xu, Donghui Zheng
INTRODUCTION: Osteoporosis, a disease of reduced bone mass and microstructural deterioration leading to fragility fractures, is becoming more prevalent as aging progresses, significantly increasing the socioeconomic burden. In past studies, there has been a growing awareness of the harmful effects of heavy metals on bone, with cadmium being a significant exposure factor. The purpose of this study was to look into the association between adult bone mineral density(BMD) and blood cadmium levels...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38577264/time-updated-fibroblast-growth-factor-23-is-predictive-for-posttransplant-diabetes-mellitus-in-kidney-transplant-recipients
#15
JOURNAL ARTICLE
Amarens van der Vaart, Daan Kremer, Tessa Niekolaas, Stephan J L Bakker, Peter R van Dijk, Martin H de Borst
OBJECTIVE: This work aimed to study whether fibroblast growth factor 23 (FGF23) is predictive for incident posttransplant diabetes mellitus (PTDM) in kidney transplant recipients (KTRs). METHODS: We repeatedly analyzed plasma C-terminal FGF23 concentrations in 170 KTRs enrolled in the TransplantLines Biobank and Cohort Study. Associations of time-updated plasma FGF23 with incident PTDM were studied by Cox regression. RESULTS: A total of 170 KTRs (46% female, aged 54...
March 12, 2024: Journal of the Endocrine Society
https://read.qxmd.com/read/38568373/asprosin-its-function-as-a-novel-endocrine-factor-in-metabolic-related-diseases
#16
REVIEW
Y Zhang, P Yang, X Zhang, S Liu, K Lou
BACKGROUND AND PURPOSE: Asprosin was discovered as a new endocrine hormone originating from fibrillin-1 cleavage that plays a crucial role in various metabolic-related diseases, such as obesity, nonalcoholic fatty liver disease (NAFLD), diabetes, polycystic ovary syndrome (PCOS), and cardiovascular diseases. The purpose of this review is to describe the recent advancements of asprosin. METHOD: Narrative review. RESULT: This comprehensive review explores its tissue-specific functions, focusing on white adipose tissue, liver, hypothalamus, testis, ovary, heart, pancreas, skeletal muscle, and kidney...
April 3, 2024: Journal of Endocrinological Investigation
https://read.qxmd.com/read/38567310/association-between-lactate-dehydrogenase-and-the-risk-of-diabetic-kidney-disease-in-patients-with-type-2-diabetes
#17
JOURNAL ARTICLE
Linqiao Tang, Qianyu Yang, Rong Ma, Ping Zhou, Cong Peng, Chunpeng Xie, Qiyuan Liang, Tingyu Wu, Wuyu Gao, Haiyan Yu, Guifei Deng, Zhen Dai, Nan Mao, Xiang Xiao
OBJECTIVE: This study aims to investigate the association between lactate dehydrogenase (LDH) and the risk of diabetic kidney disease (DKD) in patients with type 2 diabetes (T2D). METHODS: The study enrolled patients with diagnosis of T2D between 2009 and 2018 from the National Nutrition and Health Examination Survey (NHANES) database. Demographic information, laboratory test, and diagnostic data were collected. Restricted cubic spline (RCS) plots were used to assess the dose-effect relationship between LDH levels and the risk of DKD in patients with T2D...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38562415/assessing-the-causal-relationship-between-gut-microbiota-and-diabetic-nephropathy-insights-from-two-sample-mendelian-randomization
#18
JOURNAL ARTICLE
Yipeng Fang, Yunfei Zhang, Qian Liu, Zenan Zheng, Chunhong Ren, Xin Zhang
BACKGROUND: The causal association between gut microbiota (GM) and the development of diabetic nephropathy (DN) remains uncertain. We sought to explore this potential association using two-sample Mendelian randomization (MR) analysis. METHODS: Genome-wide association study (GWAS) data for GM were obtained from the MiBioGen consortium. GWAS data for DN and related phenotypes were collected from the FinngenR9 and CKDGen databases. The inverse variance weighted (IVW) model was used as the primary analysis model, supplemented by various sensitivity analyses...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38559695/the-relationship-between-weight-adjusted-waist-index-and-diabetic-kidney-disease-in-patients-with-type-2-diabetes-mellitus
#19
JOURNAL ARTICLE
Zhaoxiang Wang, Xuejing Shao, Wei Xu, Bingshuang Xue, Shao Zhong, Qichao Yang
PURPOSE: Obesity, particularly abdominal obesity, is seen as a risk factor for diabetic complications. The weight-adjusted-waist index (WWI) is a recently developed index for measuring adiposity. Our goal was to uncover the potential correlation between the WWI index and diabetic kidney disease (DKD) risk. METHODS: This cross-sectional study included adults with type 2 diabetes mellitus (T2DM) who participated in the NHANES database (2007-2018). The WWI index was calculated as waist circumference (WC, cm) divided by the square root of weight (kg)...
2024: Frontiers in Endocrinology
https://read.qxmd.com/read/38559691/current-barriers-to-initiating-insulin-therapy-in-individuals-with-type-2-diabetes
#20
REVIEW
Alba Galdón Sanz-Pastor, Alicia Justel Enríquez, Ana Sánchez Bao, Francisco Javier Ampudia-Blasco
Insulin is an essential drug in the treatment of diabetes, often necessary for managing hyperglycemia in type 2 diabetes mellitus (T2DM). It should be considered in cases of severe hyperglycemia requiring hospitalization, after the failure of other treatments, in advanced chronic kidney disease, liver cirrhosis, post-transplant diabetes, or during pregnancy. Moreover, in specific patient subgroups, early initiation of insulin is crucial for hyperglycemia control and prevention of chronic complications. Clinical guidelines recommend initiating insulin when other treatments fail, although there are barriers that may delay its initiation...
2024: Frontiers in Endocrinology
keyword
keyword
51543
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.